| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | SELL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 31.91▲ | 31.91▲ | 31.91▲ | 32.05▲ | 32.56▲ |
| MA10 | 32.09▲ | 32.09▲ | 32.12▲ | 31.79▲ | 33.39▼ |
| MA20 | 32.62▲ | 32.84▲ | 33.02▼ | 32.37▲ | 34.01▼ |
| MA50 | 33.74▼ | 33.79▼ | 33.88▼ | 33.66▼ | 33.60▼ |
| MA100 | 33.71▼ | 33.55▼ | 33.29▼ | 34.12▼ | N/A |
| MA200 | 33.22▼ | 33.63▼ | 33.79▼ | 33.31▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.061▲ | 0.025▲ | -0.026▼ | 0.153▲ | -0.326▼ |
| RSI | 51.748▲ | 50.837▲ | 49.583▼ | 53.245▲ | 47.019▼ |
| STOCH | 33.150 | 33.150 | 29.923 | 50.942 | 27.598 |
| WILL %R | 0.000▲ | 0.000▲ | -41.176 | -1.281▲ | -59.041 |
| CCI | 185.810▲ | 190.176▲ | 68.136 | 119.813▲ | -84.319 |
|
Monday, November 03, 2025 09:05 AM
(Reuters) -AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on Monday, giving it access to a deeper capital pool. The drugmaker said 99.36% ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/11/25 | 32.76 | 33.02 | 32.76 | 32.9923 | 728 |
| 25/11/25 | 32.37 | 32.7597 | 32.37 | 32.7597 | 1,349 |
| 24/11/25 | 31.78 | 32.0294 | 31.71 | 32.0294 | 6,302 |
| 21/11/25 | 31.03 | 31.685 | 31.03 | 31.6284 | 3,125 |
| 20/11/25 | 31.62 | 31.62 | 30.8572 | 30.8572 | 338 |
| 19/11/25 | 31.28 | 31.49 | 31.2734 | 31.2734 | 1,604 |
| 18/11/25 | 31.20 | 31.43 | 31.12 | 31.2861 | 1,556 |
| 17/11/25 | 31.80 | 31.8245 | 31.1548 | 31.1548 | 1,392 |
| 14/11/25 | 31.78 | 32.0367 | 31.73 | 31.9005 | 6,761 |
| 13/11/25 | 32.58 | 32.58 | 32.0379 | 32.0379 | 123 |
|
|
||||
|
|
||||
|
|